Phase II study of lenvatinib in patients with differentiated, medullary, and anaplastic thyroid cancer: Final analysis results.
暂无分享,去创建一个
K. Nakano | M. Tahara | H. Minami | N. Kiyota | C. Dutcus | K. Toda | Y. Imamura | T. Yamazaki | T. Enokida | Takuya Suzuki | L. Inagaki | N. Chayahara | S. Takahashi | Tatsuya Sasaki | K. Fujino | Kazuhisa Toda